nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Ezetimibe—atherosclerosis	0.216	0.267	CbGbCtD
Fidaxomicin—ABCB1—Simvastatin—atherosclerosis	0.201	0.248	CbGbCtD
Fidaxomicin—ABCB1—Pravastatin—atherosclerosis	0.197	0.243	CbGbCtD
Fidaxomicin—ABCB1—Lovastatin—atherosclerosis	0.197	0.243	CbGbCtD
Fidaxomicin—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00321	0.017	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00319	0.0169	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00319	0.0169	CcSEcCtD
Fidaxomicin—Abdominal distension—Niacin—atherosclerosis	0.00277	0.0147	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00277	0.0146	CcSEcCtD
Fidaxomicin—Dysphagia—Niacin—atherosclerosis	0.00276	0.0146	CcSEcCtD
Fidaxomicin—Abdominal distension—Pravastatin—atherosclerosis	0.00273	0.0144	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00265	0.014	CcSEcCtD
Fidaxomicin—Flatulence—Rosuvastatin—atherosclerosis	0.0026	0.0137	CcSEcCtD
Fidaxomicin—Angioedema—Rosuvastatin—atherosclerosis	0.00241	0.0127	CcSEcCtD
Fidaxomicin—Immune system disorder—Ezetimibe—atherosclerosis	0.00228	0.012	CcSEcCtD
Fidaxomicin—Flatulence—Lovastatin—atherosclerosis	0.0022	0.0116	CcSEcCtD
Fidaxomicin—Malnutrition—Ezetimibe—atherosclerosis	0.00219	0.0116	CcSEcCtD
Fidaxomicin—Dysgeusia—Lovastatin—atherosclerosis	0.00219	0.0116	CcSEcCtD
Fidaxomicin—Flatulence—Ezetimibe—atherosclerosis	0.00216	0.0114	CcSEcCtD
Fidaxomicin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00211	0.0112	CcSEcCtD
Fidaxomicin—Flatulence—Simvastatin—atherosclerosis	0.00206	0.0109	CcSEcCtD
Fidaxomicin—Dysgeusia—Simvastatin—atherosclerosis	0.00205	0.0108	CcSEcCtD
Fidaxomicin—Angioedema—Lovastatin—atherosclerosis	0.00204	0.0108	CcSEcCtD
Fidaxomicin—Anaemia—Ezetimibe—atherosclerosis	0.00203	0.0107	CcSEcCtD
Fidaxomicin—Angioedema—Ezetimibe—atherosclerosis	0.002	0.0106	CcSEcCtD
Fidaxomicin—Anaemia—Simvastatin—atherosclerosis	0.00193	0.0102	CcSEcCtD
Fidaxomicin—Malnutrition—Niacin—atherosclerosis	0.00192	0.0102	CcSEcCtD
Fidaxomicin—Angioedema—Simvastatin—atherosclerosis	0.00191	0.0101	CcSEcCtD
Fidaxomicin—Dyspepsia—Rosuvastatin—atherosclerosis	0.0019	0.01	CcSEcCtD
Fidaxomicin—Flatulence—Niacin—atherosclerosis	0.00189	0.01	CcSEcCtD
Fidaxomicin—Flatulence—Pravastatin—atherosclerosis	0.00186	0.00985	CcSEcCtD
Fidaxomicin—Dry mouth—Lovastatin—atherosclerosis	0.00186	0.00984	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00185	0.0098	CcSEcCtD
Fidaxomicin—Dysgeusia—Pravastatin—atherosclerosis	0.00185	0.00979	CcSEcCtD
Fidaxomicin—Constipation—Rosuvastatin—atherosclerosis	0.00184	0.00973	CcSEcCtD
Fidaxomicin—Dry mouth—Ezetimibe—atherosclerosis	0.00183	0.00965	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00176	0.00931	CcSEcCtD
Fidaxomicin—Nervous system disorder—Ezetimibe—atherosclerosis	0.00176	0.00928	CcSEcCtD
Fidaxomicin—Angioedema—Niacin—atherosclerosis	0.00175	0.00928	CcSEcCtD
Fidaxomicin—Anaemia—Pravastatin—atherosclerosis	0.00175	0.00924	CcSEcCtD
Fidaxomicin—Skin disorder—Ezetimibe—atherosclerosis	0.00174	0.00919	CcSEcCtD
Fidaxomicin—Angioedema—Pravastatin—atherosclerosis	0.00173	0.00913	CcSEcCtD
Fidaxomicin—Abdominal pain—Rosuvastatin—atherosclerosis	0.0017	0.009	CcSEcCtD
Fidaxomicin—Dyspnoea—Lovastatin—atherosclerosis	0.00163	0.0086	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00162	0.00858	CcSEcCtD
Fidaxomicin—Dyspepsia—Lovastatin—atherosclerosis	0.00161	0.00849	CcSEcCtD
Fidaxomicin—Dry mouth—Niacin—atherosclerosis	0.0016	0.00845	CcSEcCtD
Fidaxomicin—Dyspnoea—Ezetimibe—atherosclerosis	0.0016	0.00844	CcSEcCtD
Fidaxomicin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00159	0.00839	CcSEcCtD
Fidaxomicin—Decreased appetite—Lovastatin—atherosclerosis	0.00159	0.00839	CcSEcCtD
Fidaxomicin—Dyspepsia—Ezetimibe—atherosclerosis	0.00158	0.00833	CcSEcCtD
Fidaxomicin—Constipation—Lovastatin—atherosclerosis	0.00156	0.00825	CcSEcCtD
Fidaxomicin—Decreased appetite—Ezetimibe—atherosclerosis	0.00156	0.00823	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00155	0.00817	CcSEcCtD
Fidaxomicin—Constipation—Ezetimibe—atherosclerosis	0.00153	0.00809	CcSEcCtD
Fidaxomicin—Pruritus—Rosuvastatin—atherosclerosis	0.00152	0.00805	CcSEcCtD
Fidaxomicin—Skin disorder—Niacin—atherosclerosis	0.00152	0.00805	CcSEcCtD
Fidaxomicin—Dyspnoea—Simvastatin—atherosclerosis	0.00152	0.00804	CcSEcCtD
Fidaxomicin—Dyspepsia—Simvastatin—atherosclerosis	0.0015	0.00794	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00149	0.00789	CcSEcCtD
Fidaxomicin—Decreased appetite—Simvastatin—atherosclerosis	0.00148	0.00784	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00147	0.00779	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00146	0.00774	CcSEcCtD
Fidaxomicin—Constipation—Simvastatin—atherosclerosis	0.00146	0.00772	CcSEcCtD
Fidaxomicin—Abdominal pain—Lovastatin—atherosclerosis	0.00144	0.00763	CcSEcCtD
Fidaxomicin—Dizziness—Rosuvastatin—atherosclerosis	0.00142	0.00753	CcSEcCtD
Fidaxomicin—Abdominal pain—Ezetimibe—atherosclerosis	0.00141	0.00748	CcSEcCtD
Fidaxomicin—Dyspnoea—Niacin—atherosclerosis	0.0014	0.00739	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0014	0.00738	CcSEcCtD
Fidaxomicin—Dyspepsia—Niacin—atherosclerosis	0.00138	0.00729	CcSEcCtD
Fidaxomicin—Dyspnoea—Pravastatin—atherosclerosis	0.00138	0.00727	CcSEcCtD
Fidaxomicin—Decreased appetite—Niacin—atherosclerosis	0.00136	0.0072	CcSEcCtD
Fidaxomicin—Dyspepsia—Pravastatin—atherosclerosis	0.00136	0.00718	CcSEcCtD
Fidaxomicin—Rash—Rosuvastatin—atherosclerosis	0.00136	0.00718	CcSEcCtD
Fidaxomicin—Dermatitis—Rosuvastatin—atherosclerosis	0.00136	0.00717	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00135	0.00715	CcSEcCtD
Fidaxomicin—Abdominal pain—Simvastatin—atherosclerosis	0.00135	0.00713	CcSEcCtD
Fidaxomicin—Headache—Rosuvastatin—atherosclerosis	0.00135	0.00713	CcSEcCtD
Fidaxomicin—Hypersensitivity—Lovastatin—atherosclerosis	0.00134	0.00711	CcSEcCtD
Fidaxomicin—Decreased appetite—Pravastatin—atherosclerosis	0.00134	0.00709	CcSEcCtD
Fidaxomicin—Constipation—Pravastatin—atherosclerosis	0.00132	0.00698	CcSEcCtD
Fidaxomicin—Hypersensitivity—Ezetimibe—atherosclerosis	0.00132	0.00697	CcSEcCtD
Fidaxomicin—Pruritus—Lovastatin—atherosclerosis	0.00129	0.00683	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Niacin—atherosclerosis	0.00128	0.00678	CcSEcCtD
Fidaxomicin—Nausea—Rosuvastatin—atherosclerosis	0.00128	0.00676	CcSEcCtD
Fidaxomicin—Pruritus—Ezetimibe—atherosclerosis	0.00127	0.00669	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00126	0.00667	CcSEcCtD
Fidaxomicin—Hypersensitivity—Simvastatin—atherosclerosis	0.00126	0.00665	CcSEcCtD
Fidaxomicin—Abdominal pain—Niacin—atherosclerosis	0.00124	0.00655	CcSEcCtD
Fidaxomicin—Abdominal pain—Pravastatin—atherosclerosis	0.00122	0.00645	CcSEcCtD
Fidaxomicin—Pruritus—Simvastatin—atherosclerosis	0.00121	0.00638	CcSEcCtD
Fidaxomicin—Dizziness—Lovastatin—atherosclerosis	0.00121	0.00638	CcSEcCtD
Fidaxomicin—Dizziness—Ezetimibe—atherosclerosis	0.00118	0.00626	CcSEcCtD
Fidaxomicin—Vomiting—Lovastatin—atherosclerosis	0.00116	0.00613	CcSEcCtD
Fidaxomicin—Hypersensitivity—Niacin—atherosclerosis	0.00115	0.0061	CcSEcCtD
Fidaxomicin—Rash—Lovastatin—atherosclerosis	0.00115	0.00608	CcSEcCtD
Fidaxomicin—Dermatitis—Lovastatin—atherosclerosis	0.00115	0.00608	CcSEcCtD
Fidaxomicin—Headache—Lovastatin—atherosclerosis	0.00114	0.00604	CcSEcCtD
Fidaxomicin—Vomiting—Ezetimibe—atherosclerosis	0.00114	0.00602	CcSEcCtD
Fidaxomicin—Hypersensitivity—Pravastatin—atherosclerosis	0.00114	0.00601	CcSEcCtD
Fidaxomicin—Dizziness—Simvastatin—atherosclerosis	0.00113	0.00597	CcSEcCtD
Fidaxomicin—Rash—Ezetimibe—atherosclerosis	0.00113	0.00597	CcSEcCtD
Fidaxomicin—Dermatitis—Ezetimibe—atherosclerosis	0.00113	0.00596	CcSEcCtD
Fidaxomicin—Headache—Ezetimibe—atherosclerosis	0.00112	0.00593	CcSEcCtD
Fidaxomicin—Pruritus—Niacin—atherosclerosis	0.00111	0.00586	CcSEcCtD
Fidaxomicin—Pruritus—Pravastatin—atherosclerosis	0.00109	0.00577	CcSEcCtD
Fidaxomicin—Vomiting—Simvastatin—atherosclerosis	0.00109	0.00574	CcSEcCtD
Fidaxomicin—Nausea—Lovastatin—atherosclerosis	0.00108	0.00573	CcSEcCtD
Fidaxomicin—Rash—Simvastatin—atherosclerosis	0.00108	0.00569	CcSEcCtD
Fidaxomicin—Dermatitis—Simvastatin—atherosclerosis	0.00108	0.00568	CcSEcCtD
Fidaxomicin—Headache—Simvastatin—atherosclerosis	0.00107	0.00565	CcSEcCtD
Fidaxomicin—Nausea—Ezetimibe—atherosclerosis	0.00106	0.00562	CcSEcCtD
Fidaxomicin—Dizziness—Niacin—atherosclerosis	0.00104	0.00548	CcSEcCtD
Fidaxomicin—Dizziness—Pravastatin—atherosclerosis	0.00102	0.00539	CcSEcCtD
Fidaxomicin—Nausea—Simvastatin—atherosclerosis	0.00101	0.00536	CcSEcCtD
Fidaxomicin—Vomiting—Niacin—atherosclerosis	0.000996	0.00527	CcSEcCtD
Fidaxomicin—Rash—Niacin—atherosclerosis	0.000988	0.00522	CcSEcCtD
Fidaxomicin—Dermatitis—Niacin—atherosclerosis	0.000987	0.00522	CcSEcCtD
Fidaxomicin—Headache—Niacin—atherosclerosis	0.000982	0.00519	CcSEcCtD
Fidaxomicin—Vomiting—Pravastatin—atherosclerosis	0.000981	0.00519	CcSEcCtD
Fidaxomicin—Rash—Pravastatin—atherosclerosis	0.000973	0.00514	CcSEcCtD
Fidaxomicin—Dermatitis—Pravastatin—atherosclerosis	0.000972	0.00514	CcSEcCtD
Fidaxomicin—Headache—Pravastatin—atherosclerosis	0.000967	0.00511	CcSEcCtD
Fidaxomicin—Nausea—Niacin—atherosclerosis	0.000931	0.00492	CcSEcCtD
Fidaxomicin—Nausea—Pravastatin—atherosclerosis	0.000916	0.00485	CcSEcCtD
